2021
DOI: 10.3390/microorganisms9051021
|View full text |Cite
|
Sign up to set email alerts
|

Role of Gut Microbiota and Probiotics in Colorectal Cancer: Onset and Progression

Abstract: The gut microbiota plays an important role in maintaining homeostasis in the human body, and the disruption of these communities can lead to compromised host health and the onset of disease. Current research on probiotics is quite promising and, in particular, these microorganisms have demonstrated their potential for use as adjuvants for the treatment of colorectal cancer. This review addresses the possible applications of probiotics, postbiotics, synbiotics, and next-generation probiotics in colorectal cance… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
38
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(39 citation statements)
references
References 156 publications
(199 reference statements)
0
38
0
1
Order By: Relevance
“…Probiotics show promise as agents of host–microbiome modulation therapies for several diseases, including CRC (Torres-Maravilla et al 2021 ). It has been proposed that probiotics may minimize the development and progression of CRC by mitigating the aggressiveness of tumors.…”
Section: Gut Microbiota In Gi Cancermentioning
confidence: 99%
See 1 more Smart Citation
“…Probiotics show promise as agents of host–microbiome modulation therapies for several diseases, including CRC (Torres-Maravilla et al 2021 ). It has been proposed that probiotics may minimize the development and progression of CRC by mitigating the aggressiveness of tumors.…”
Section: Gut Microbiota In Gi Cancermentioning
confidence: 99%
“…It has been proposed that probiotics may minimize the development and progression of CRC by mitigating the aggressiveness of tumors. Bacillus and Saccharomyces and next-generation probiotics are currently tested in clinical trials (Torres-Maravilla et al 2021 ).…”
Section: Gut Microbiota In Gi Cancermentioning
confidence: 99%
“…305 Currently, only a few studies have indicated that probiotics are effective in preventing CRC. 306 Animal experiments have shown that probiotics can significantly reduce the tumor burden in mice with UCassociated malignancy, which is related to the downregulation of inflammatory factors in the intestinal mucosa, such as TNF-α and IL-6, and inhibition of the NF-κB pathway. 307,308 Their role in the prevention of IBD carcinogenesis needs to be verified in clinical trials.…”
Section: Grade Of Recommendation: Amentioning
confidence: 99%
“…Thus, synbiotics could be novel therapeutic approaches to strengthen the gut microbiome for protective effects against CRC through alleviating inflammation and preventing tumorigenesis. However, due to the concerns of consuming live microbial species and uncertainties about the net effects of its colonization in the gut, postbiotics are gaining increasing attention as a paradigm shift ( 122 , 123 ). Postbiotics are composed of inactivated microbial cells or their components with or without microbial metabolites, which shows beneficial effects on human health ( 124 ).…”
Section: The Effects Of Dietary Interventions On Colorectal Cancermentioning
confidence: 99%